Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-047191
Filing Date
2012-08-23
Accepted
2012-08-23 16:06:47
Documents
1
Period of Report
2012-08-21

Document Format Files

Seq Description Document Type Size
1 rrd354240.html 4  
1 rrd354240.xml 4 8671
  Complete submission text file 0001181431-12-047191.txt   10106
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Issuer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THREE ARCH PARTNERS 3200 ALPINE RD PORTOLA VALLEY CA 94028
Business Address
JAEGER WILFRED E (Reporting) CIK: 0001190474 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-32979 | Film No.: 121052232